Neuralink’s Ambitious Plans for Brain-Computer Interface Technology
Elon Musk has hailed his company’s Neuralink brain-computer interface technology as a groundbreaking innovation. Recently, Neuralink’s president announced aspirations to implant chips in healthy individuals within the next four years, with Musk referring to the technology as “Jesus-level technology.” This came during a virtual session at the Samsung International Smart Mobility Summit held in Tel Aviv, where Musk shared his high hopes for Neuralink from Texas.
He emphasized the technology’s promise to restore movement and vision, labeling it a significant scientific advancement. “Regaining control and restoring vision to quadriplegics is quite a hefty challenge,” Musk told attendees. “Those are what I call Jesus-level technologies—miracles in a scientific sense.”
Additonally, Musk discussed the future capabilities of Neuralink’s Blindsight product. He hinted that it could offer “perhaps superhuman vision” to those with visual impairments. This system is designed to bypass damaged eyes, transmitting visual information straight to the brain’s visual cortex. The plan is to begin implementing BlindSight in its initial patients by late 2026.
However, the most noteworthy update came from Neuralink’s president, DJ Seo, who stated that the company aims to start chip implants in “otherwise healthy people” by 2030. This pivot suggests a shift from strictly medical use to potential consumer applications of the technology.
This progression raises interesting questions about transhumanism and whether healthy individuals might feel compelled to embrace such technology if it becomes widely available, even outside of medical necessity.
The company has reported significant advancements in its clinical trials. As of January, Neuralink had 21 participants involved in its trials, an increase from 12 patients in September 2025. With their telepathic chips, those with spinal cord injuries can perform remarkable tasks using only their thoughts, like controlling computers, surfing the web, and manipulating robotic limbs.
Noland Arbaugh, the first human to receive a Neuralink implant, is a quadriplegic who underwent the procedure in January 2024. He has showcased the chip’s functionality by playing video games, sending messages, and even designing 3D models, all by moving his head. These achievements highlight the potential applications of this technology for those with serious mobility challenges.
Moreover, Neuralink has gained substantial financial backing, announcing a $650 million Series E funding round to broaden patient access to its technology.
